Medicare Enrolled

Dr. Ahmed Haque, MD

Anesthesiology · Richardson, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
990 S SHERMAN ST, Richardson, TX 75081
9727880350
In practice since 2017 (8 years)
NPI: 1487184628 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haque from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haque? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haque

Dr. Ahmed Haque is an anesthesiology specialist in Richardson, TX, with 8 years of NPI registration. Based on federal Medicare data, Dr. Haque performed 3,835 Medicare services across 1,152 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haque received a total of $3,009 from 17 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haque is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice ▲ Top 3% volume in TX $3,009 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,835
Medicare services
Top 3% in TX for anesthesiology
1,152
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~479 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,452 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
359 $93 $254
Contrast dye for imaging, lower concentration 287 $0 $3
Additional sedation, per 15 minutes
Administration of a drug to deepen sedation during a procedure. This code covers each additional 15-minute increment of sedation beyond the initial period.
223 $8 $22
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
194 $61 $162
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
188 $31 $104
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
182 $195 $402
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
118 $38 $99
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
114 $120 $379
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
94 $9 $25
Injection, methylprednisolone acetate, 40 mg 89 $6 $14
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
66 $200 $809
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
65 $103 $422
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
62 $197 $758
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
56 $63 $180
Fluoroscopic guidance for needle placement
Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure.
46 $86 $180
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
43 $52 $139
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
39 $148 $474
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
26 $216 $915
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
26 $110 $513
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
25 $258 $709
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
24 $470 $1,629
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
22 $204 $716
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
18 $200 $758
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
17 $85 $344
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,009
Total received (2019-2024)
Avg $602/year across 5 years
Top 10% in TX for anesthesiology
17
Companies
67
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,009 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$251
2023
$421
2022
$494
2021
$1,833
2019
$11

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$875
Boston Scientific Corporation
$558
BOSTON SCIENTIFIC CORPORATION
$558
Nevro Corp.
$414
BIOTRONIK NRO, Inc.
$108
Abbott Laboratories
$80
SI-BONE, INC.
$69
PFIZER INC.
$63
Stryker Corporation
$60
Forte Bio-Pharma LLC
$57
ABBVIE INC.
$42
Averitas Pharma Inc.
$32
Scilex Pharmaceuticals Inc.
$29
Saluda Medical Americas, Inc.
$26
Lundbeck LLC
$17
Kowa Pharmaceuticals America, Inc.
$12
SI-BONE, Inc.
$11
Top 3 companies account for 66.1% of total payments
Associated products mentioned in payments ›
BIOTRONIK · ETERNA · Evoke · GENERAL - PAIN MANAGEMENT · General - Pain Management · INTELLIS · INTELLIS ADAPTIVESTIM · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · NALOCET · NURTEC ODT · Omnia · PROCLAIM · PROLATE · Prospera · QULIPTA · QUTENZA · SPINEJACK · Seglentis · Senza · UBRELVY · V-LOC 180 · VYEPTI · WAVEWRITER ALPHA · ZTLido · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for anesthesiology in TX.

Equivalent to $78 per 100 Medicare services performed
Looking for an anesthesiology specialist in Richardson?
Compare anesthesiologists in the Richardson area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologists nearby

Geographic Context

Anesthesiologists within 10 mi
1,319
Per 100K population
50.7
County median income
$74,149
Nearest hospital
NEXUS CHILDRENS HOSPITAL DALLAS
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Haque is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), with low-engagement industry engagement in the top 10% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Haque experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Haque performed 1,452 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haque receive payments from pharmaceutical companies?
Yes. Dr. Haque received a total of $3,009 from 17 companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haque's costs compare to other anesthesiologists in Richardson?
Dr. Haque's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haque) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →